Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2007 Oct;86(4):1202-9.
doi: 10.1093/ajcn/86.4.1202.

Folic acid supplementation lowers blood arsenic

Mary V Gamble  1 , Xinhua Liu, Vesna Slavkovich, J Richard Pilsner, Vesna Ilievski, Pam Factor-Litvak, Diane Levy, Shafiul Alam, Mominul Islam, Faruque Parvez, Habibul Ahsan, Joseph H Graziano
Affiliations
Randomized Controlled Trial

Folic acid supplementation lowers blood arsenic

Mary V Gamble et al. Am J Clin Nutr. 2007 Oct.

Abstract

Background: Chronic arsenic exposure currently affects >100 million persons worldwide. Methylation of ingested inorganic arsenic (InAs) to monomethylarsonic (MMAs) and dimethylarsinic (DMAs) acids relies on folate-dependent one-carbon metabolism and facilitates urinary arsenic elimination.

Objective: We hypothesized that folic acid supplementation to arsenic-exposed Bangladeshi adults would increase arsenic methylation and thereby lower total blood arsenic.

Design: In this randomized, double-blind, placebo-controlled trial, we evaluated blood concentrations of total arsenic, InAs, MMAs, and DMAs in 130 participants with low plasma folate (<9 nmol/L) before and after 12 wk of supplementation with folic acid (400 microg/d) or placebo.

Results: MMAs in blood was reduced by a mean +/- SE of 22.24 +/- 2.86% in the folic acid supplementation group and by 1.24 +/- 3.59% in the placebe group (P < 0.0001). There was no change in DMAs in blood; DMAs is rapidly excreted in urine as evidenced by an increase in urinary DMAs (P = 0.0099). Total blood arsenic was reduced by 13.62% in the folic acid supplementation group and by 2.49% in the placebo group (P = 0.0199).

Conclusions: Folic acid supplementation to participants with low plasma concentrations of folate lowered blood arsenic concentrations, primarily by decreasing blood MMAs and increasing urinary DMAs. Therapeutic strategies to facilitate arsenic methylation, particularly in populations with folate deficiency or hyperhomocysteinemia or both, may lower blood arsenic concentrations and thereby contribute to the prevention of arsenic-induced illnesses.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Mean (±SE) percentage change in total blood arsenic from baseline after supplementation for 12 wk with folic acid ( formula image) (n = 68) or placebo (□) (n = 62) (P = 0.02).
FIGURE 2
FIGURE 2
Baseline blood concentrations of monomethylarsonic acid (MMAs; μg/L) for each participant (♦) in the folic acid (A) and placebo (B) groups. — (smoothed by sorting on baseline MMAs), the range of MMAs at baseline (1–15 μg/L); formula image, each participant’s corresponding blood MMAs after the 12-wk intervention. Rising and falling vertical bars indicate each participant’s increase or decrease, respectively, in blood MMAs from that participant’s baseline.
FIGURE 3
FIGURE 3
Mean (±SD) percentage of arsenic in blood and in urine at baseline in 130 participants. □, the percentage of total urinary arsenic present as inorganic arsenic (InAs), monomethylarsonic acid (MMAs), and dimethylarsinic acid (DMAs) in urine; formula image, the percentage of total blood arsenic as InAs, MMAs, and DMAs in blood. Plotted values are the mean ± SD for 130 participants at baseline.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ahmed MF, Ahuja S, Alauddin M, et al. Ensuring safe drinking water in Bangladesh. Science. 2006;314:1687–8. - PubMed
    1. Kinniburgh DG, Smedley PL. Arsenic contamination of groundwater in Bangladesh. Keyworth, United Kingdom: British Geological Survey; 2001. Final Report: BGS Technical Report WC/00/19.
    1. Chiou HY, Huang WI, Su CL, Chang SF, Hsu YH, Chen CJ. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke. 1997;28:1717–23. - PubMed
    1. Tseng CH, Chong CK, Tseng CP, et al. Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. Toxicol Lett. 2003;137:15–21. - PubMed
    1. Feldman RG, Niles CA, Kelly-Hayes M, et al. Peripheral neuropathy in arsenic smelter workers. Neurology. 1979;29:939–44. - PubMed

Publication types

MeSH terms